Alice Pau

TL;DR: The most recent version of the guidelines for the prevention and treatment of opportunistic infections (OI) in HIV-infected adults and adolescents was published in 2002 and 2004, respectively as mentioned in this paper.

TL;DR: These guidelines are intended for clinicians and other health-care providers who care for HIV-infected adults and adolescents, including pregnant women, and include evidence-based guidelines for treatment of 28 OIs caused by protozoa, bacteria, fungi, and viruses.

TL;DR: It is demonstrated that defective proviruses that persist in HIV-infected individuals during suppressive cART are translationally competent and produce the HIV-1 Gag and Nef proteins, which may trigger an element of innate immunity.

TL;DR: In the United States, the incidence of HIVassociated opportunistic infections (OIs) has decreased dramatically, resulting from improvements in and the diffusion of effective OI prophylaxis, but most importantly, they have resulted from the advent of combination antiretroviral therapy.

TL;DR: The CDC National Institutes of Health and the HIV Medicine Association of the Infectious Diseases Society of America have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunodeficiency virus (HIV).